Abbreviations Used in Chapter 22
| ACC | American College of Cardiology |
| ACE | angiotensin-converting enzyme |
| ACEI | angiotensin-converting enzyme inhibitor |
| ACS | acute coronary syndrome |
| ACTION | Acute Coronary Treatment and Intervention Outcomes Network |
| AED | automated external defibrillator |
| AF | atrial fibrillation |
| AHA | American Heart Association |
| AMI | acute myocardial infarction |
| ARB | angiotensin receptor blocker |
| BMI | body mass index |
| BP | blood pressure |
| CABG | coronary artery bypass grafting |
| CAD | coronary artery disease |
| CHD | coronary heart disease |
| CHF | congestive heart failure |
| CI | confidence interval |
| COURAGE | Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation |
| CPR | cardiopulmonary resuscitation |
| CRUSADE | Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines |
| CVD | cardiovascular disease |
| D2B | Door-to-Balloon (Alliance) |
| DES | drug-eluting stent |
| DM | diabetes mellitus |
| DVT | deep vein thrombosis |
| ECG | electrocardiogram |
| ED | emergency department |
| EF | ejection fraction |
| EMS | emergency medical services |
| GBD | Global Burden of Diseases, Injuries, and Risk Factors Study |
| GWTG | Get With The Guidelines |
| HbA1c | hemoglobin A1c (glycosylated hemoglobin) |
| HD | heart disease |
| HF | heart failure |
| HIQR | Hospital Inpatient Quality Reporting |
| HR | hazard ratio |
| IV | intravenous |
| LDL | low-density lipoprotein |
| LV | left ventricular |
| LVEF | left ventricular ejection fraction |
| LVSD | left ventricular systolic dysfunction |
| MI | myocardial infarction |
| N/A | not available or not applicable |
| NCDR | National Cardiovascular Data Registry |
| NHANES | National Health and Nutrition Examination Survey |
| NM | not measured |
| NSTEMI | non–ST-segment–elevation myocardial infarction |
| OR | odds ratio |
| PAD | peripheral artery disease |
| PCI | percutaneous coronary intervention |
| PINNACLE | Practice Innovation and Clinical Excellence |
| RR | relative risk |
| SBP | systolic blood pressure |
| SCD-HeFT | Sudden Cardiac Death in Heart Failure Trial |
| STEMI | ST-segment–elevation myocardial infarction |
| STS | Society of Thoracic Surgeons |
| TAVR | transcatheter aortic valve replacement |
| tPA | tissue-type plasminogen activator |
| TVR | target-vessel revascularization |
| TVT | transcatheter valve therapy |
| UFH | unfractionated heparin |
| VHA | Veterans Health Administration |
| YLL | years of life lost |